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LABORATORY INVESTIGATION
Retinoic acid affects the cell cycle and increases total protein
content in epithelial cells
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Retinoic acid affects the cell cycle and increases total protein content in
epithelial cells. Retinoids and particularly retinoic acid (RA) have been
incriminated in the adaptation to uninephrectomy and compensatory
kidney growth in humans. However, there is no data assessing the
effects of RA on renal cells. Since the bulk of the compensatory kidney
growth is due to tubular cells, we studied the effects of RA, retinol and
epidermal growth factor (EGF) on a rabbit kidney epithelial cell line
RKI3 in culture. RA significantly increased thymidine incorporation by
42 8% (P < 0.01). This increase appeared as soon as three hours after
adding RA and could still be observed after five days. Total protein
content was also increased by RA by 37 4% (P < 0.01). Flow
cytometer analysis showed a significant decrease in the percentage of
resting cells (G0-Gl phases) induced by RA (—9.4 2%; P < 0.01). We
observed similar results in growth factor free medium, and the RA
induced changes were the same in confluent and non-confluent cells.
Retinol did not modify thymidine incorporation or total protein content.
EGF increased by 75% thymidine incorporation (P < 0.01). In serum
free conditions RA failed to have a synergistic effect with EGF. These
data show that RA is able to induce modifications in kidney epithelial
cells compatible with those observed in hypertrophy while retinol is
not. These modifications are not due to other growth factor potentiation
but to RA itself, and are independent of the contact-inhibition phenom-
enon.
Retinoic acid is one of a family of chemicals derived from
vitamin A (retinol) which occur naturally or may be synthe-
sized, and which are termed retinoids [I]. These substances
support visual and reproductive functions and can modulate cell
differentiation and proliferation. These properties have already
brought them into limited clinical use in the areas of dermatol-
ogy and oncology [2—5].
Much of the information about retinoids is derived from in
vitro studies using various cell lines or primary cell isolates
[6—9]. Retinoids, and particularly retinoic acid, modulate phe-
notypic transformation of normal rat kidney fibroblasts, a
property they share with transforming growth factor (TGF) beta
[10]. Retinoic acid can also potentiate the activity of epidermal
growth factor (EGF) and platelet-derived growth factor (PDGF)
in these cells [10].
The mechanism of action of retinoids is not completely
understood, but it seems likely that they act at the genomic
level by causing enhanced transcription via the activation of a
specific receptor cascade [11]. Cellular retinoic acid binding
protein (CRABP) is a cytosolic protein able to specifically bind
retinoic acid that was thought to directly mediate its nuclear
effects [12]. Recently, other cellular retinoic acid receptors
have been identified which display similar structures to those of
the previously described receptors for steroid hormones, thy-
roid hormone, and vitamin D3 [11, 13—15]. This family of
receptors displays a common, highly conserved DNA binding
region, a specific ligand receptor area and a variable amino
terminal region [11, 13—16].
We have recently observed local modification of CRABP
metabolism in the remaining kidney following unilateral ne-
phrectomy in humans [17]. This finding, in addition to an
increase in serum levels of retinol and retinol binding protein
after nephrectomy led us to postulate a participation of retinol
metabolism in compensatory kidney growth [17]. Studies on
retinol metabolism have established that porcine renal epithelial
LLC-PK cells convert retinol and retinal into retinoic acid [18].
However, there are no previous studies monitoring the biolog-
ical activity of retinoic acid on renal tubular cells. Since the
bulk of compensatory kidney growth is due to tubular cells [19,
20], we monitored the metabolic changes induced by retinoic
acid on a rabbit kidney epithelial cell line.
Methods
Cell culture
We used rabbit kidney epithelial cells (RK13) [211 (Common-
wealth Serum Laboratories of Australia) as in previous reports
in which they were used to study compensatory kidney growth
and humoral growth factors [22]. RK13 were cultured in RPM!
1640 (GIBCO) medium supplemented with 10% fetal bovine
serum (FCS) (GIBCO). The cells were grown in plastic flasks.
For protein and 3H-thymidine incorporation analyses, the cells
were trypsinized and subcultured in 96 well trays at 8000
cells/well with RPM! 1640 containing 10% FCS.
Growth factors and growth factor-free medium
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The concentration of RA used (10 M) was derived from
previous reports where this concentration was found to be
active [6]. Dose response studies gave the maximum response
at l0 KS RA, no effect at l0 and half-maximum effect at i0
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Table 1. 3H-thymidine uptake
Experiment
1 2 3 4 5 6
RA— 19815 2433 9433 226 6873 697 8659 464 21743 461 5822 144
RA+ 29656 2159 16122 548 8947 249 9430 656 30743 1735 9032 362
% Increase 50% 70% 30% 9% 42% 55%
P value <0.05 <0.05 <0.05 NS <0.05 <0.05
3H-thymidine incorporation (in C.P.M.) by RK13 cells in the presence (RA+) or absence of retinoic acid (RA—). Twelve replicates were done
in each experiment, values are mean standard error.
M. Retinol (vitamin A) was tested at l0— M. To study the
effects of epidermal growth factor (EGF), 1 ng!well was added
(in dose response studies on a human kidney epithelial and rat
mesangial cell lines, we found 1 ng/well to induce maximal
response). To test RA in growth factor-free medium we fol-
lowed the procedure used by Van Zoelen, van Oostwaard and
de Laat [23] by which they were able to determine the isolated
effects of different growth factors 72 hours after replacing a 10%
FCS supplemented medium with FCS free one. We first as-
sessed the tolerance of RK13 cells to FCS free medium.
Following trypsinization, the RK13 cells were washed thrice
with PBS and resuspended and subcultured in serum-free RPM!
1640. Cell shape was stable until day 4. Subsequently, the cells
underwent shape modifications and finally died. RA was tested
in two experiments where the cells were subcultured and
maintained for three days without FCS. The same serum-free
medium was used to assess the effect of EGF in the presence or
absence of RA. The incubation time for the growth factors was
18 hours in all experiments, whether they were for thymidine
incorporation, total protein determination or cell cycle analysis,
unless otherwise specified.
Thymidine incorporation
3H radiolabeled thymidine (27 Ci/mmol; Amersham Interna-
tional, Amersham, UK) was added (0.5 tCiIwell) for 90 minutes
at 37°C. The medium was then removed, the wells were washed
thrice with 200 ,ul of warm PBS, and two successive aliquots of
50 d 0.2 N NaOH were added and left at 37°C for 10 minutes
prior to counting in scintillation vials containing 100 d 0.2 N
HC1 and 3.5 ml of scintillation fluid. A LKB WALLAC 1214
(LKB, Upsala, Sweden) beta counter was used. Each experi-
ment was performed with 12 replicates.
Protein determinations
After washing the wells three times with warm PBS, 300 d of
0.08 N HC1, 0.15 N NaC1 containing 0.1% Triton X-100 solution
was added and incubated for 15 minutes at 37°C to lyse the
cells. Protein content of the wells was determined according to
the Bradford technique as modified by Spector [24]; four points
per well were read in a LKB ultraspect II (LKB, Upsala,
Sweden) spectophotometer. Only correlation coefficient values
of greater than 0.99 for the four points were accepted. Six wells
were assessed in each experiment.
DNA staining and cell phase analyses
Cell preparation for EPICS analysis. Cells were washed
three times with PBS and removed from the flasks after 0.1%
trypsin incubation for 30 minutes. Single cell preparations were
achieved by resuspension with a Pasteur pipette. Cells were
then suspended in sterile PBS at 106 cells/ml. Nucleic acids
were stained according to Traganos et a! [251. Two hundred 1.d
of cell suspension were added into 400 d of 0.1% Triton X
solution at 4°C, shaken and incubated for 15 seconds and 1.2 ml
of Acridine Orange (6 p.g/ml) l0 M EDTA-Na, 0.15 N NaCI,
0.2 M Na2HPO4, 0.1 M citric acid, pH 6 solution were added.
The cells were analyzed on the EPICS within two minutes.
Four hundred d of DNase (1 mg/mI) or RNase (2000 U/mI; both
from Worthington Biochem Corp., USA) solutions were added
and incubated for 30 minutes at 37°C before adding Acridine
orange in control experiments.
Flow cytometry analysis. The cells were analyzed on a
EPICS 752 (Coulter Electronics, Miami, Florida, USA) flow
cytometer. The EPICS Argon laser was tuned to a wavelength
of 488 nm, at a power of 600 mW, for excitation of the Acridine
orange dye. Size measurements of the cells were based on light
scatter (wavelength = 488 nm) collected in the forward angle
(FALS), and right angle (9OLS) directions. From these mea-
surements it was possible to distinguish the stained cell popu-
lation from the cellular debris. Fluorescent measurements for
DNA emissions were detected through a 530 15 nm band pass
filter. Fluorescence scattergrams and single color histograms
for the DNA emissions were measured for the gated cell
population on the FALS versus 90 LS scattergram. The DNA
cell cycle analysis was performed with the PARA 1 software
package. This package assumes gaussian distributions for both
the GOG1 and G2+M cells, and calculates the percentage of
cells in these peaks and then measures the percentage of cells in
S phase by substracting the other phases from the total.
Statistical analysis
Values are given as mean standard error of the mean.
Student's t-test was used to compare the results in each
experiment. The paired t-test was performed for paired data
resulting from difference of the RA and control means in each
experiment, when several experiments were analyzed.
Results
Effect of retinoic acid, retinol and EGF on thymidine
incorporation
Retinoic acid caused increased thymidine incorporation in all
experiments using cells in logarithmic growth phase. The ex-
periments performed are displayed in Table 1. The increase was
significant (t-test, P < 0.05) in five out of six experiments.
Analysis of the six experiments showed an average increase of
42± 8% (P < 0.01).
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Table 2. RA effect on confluent cells
Experiment
1 2 3
RA—
RA+
%Increase
P value
4939 97
5838 141
18%
<0.05
4260 88
5680 156
33%
<0.05
4650
5170
11%
NS
196
316
3H-thymidine incorporation in confluent cells in the presence (RA+)
or absence (RA—) of RA. Twelve replicates were done in each
experiment, values are mean standard error.
Table 3. RA effect in serum free conditions
Experiment
1 2
RA—
RA+
% Increase
P value
2431 93
4335 205
78%
<0.05
2612 107
3019 54
16%
<0.05
3H-thymidine incorporation in RKI3 cells grown in growth factor-
free medium (Methods), Twelve replicates were done in each experi-
ment, values are mean standard error.
Table 4. Kinetics of 3H-thymidine uptake
Hour3 Hour6 Day I Day2 Day3 Day4
RA— 12055 516 15093 453 5822 144 9356 319 13156 299 5389 237
RA+ 14119 452 16053 320 9032 362 13097 487 14932 441 6620 279
% Increase 17% 6% 55% 40% 14% 23%
P value <0.05 NS <0.05 <0.05 <0.05 <0.05
Kinetics of 3H-thymidine incorporation increases induced by retinoic acid, 3 and 6 hours as well as Ito 4 days after adding retinoic acid. Twelve
replicates were performed in each experiment, values are mean standard error.
To assess the effect of RA on cells affected by contact
inhibition three experiments were performed with confluent
cells. Again RA increased thymidine incorporation in these
experiments and significantly in two of them (11%, +33% and
+ 18%; Table 2). Two supplementary experiments were per-
formed in growth factor-free conditions on confluent cells to
determine whether the increased thymidine incorporation in-
duced by RA was dependent on FCS in the cultures. In both
experiments thymidine incorporation increased again and sig-
nificantly in both (+78% and + 16%, respectively; Table 3).
These cells had been cultured and maintained for three days in
the absence of FCS prior to the addition of RA in order to avoid
the carryover of any serum derived growth factors.
Thymidine incorporation was studied at 3, 6, 24, 48, 72, and
96 hours as well as five days after adding RA. Increased
thymidine incorporation was already significant at three hours
and remained significantly greater until the experiment was
completed at day 5 (Table 4). We repeated the kinetic studies
and found comparable results: an increase at three hours which
was significant at six hours, as well in the last days of the
experiment.
As shown in Table 5, retinol did not induce any modification
in thymidine incorporation in RK13 cells. The experiment was
performed twice with similar results. On the other hand, EGF
increased thymidine incorporation by 75%. In the same exper-
iment RA again significantly increased thymidine incorporation,
but failed to potentiate EGF activity (Table 6).
Protein analysis
The total protein content of the wells was increased by RA
(Fig. 1). On each of five occasions total proteins were signifi-
cantly higher in wells containing RA. The mean of the increases
was 37 4% (P < 0.01).
Cell cycle analyses
Acridine orange staining enabled accurate assessment of
DNA cell distribution patterns (Fig. 2). RA induced a significant
and constant decrease in the percentage of cells in G0-G I phase
in all five experiments (—9.4 2%, P < 0.01, Fig. 3). The same
analysis on confluent cells yielded the same result in three
experiments: RA decreased the percentage of cells in G0-Gl
phase by —7, —4 and —8%, respectively. As was expected, the
percentage of cells in G2-M was greater in exponentially
growing cells than in confluent cells (Fig. 2). In the latter, the
percentage of resting cells (00-01) was higher, and this was
observed regardless of the presence of RA. The percentage of
resting cells was higher in confluent preparations by 38 11%
in the presence of RA and by 41 9% in the absence of RA; the
percentage of cells in G2-M was decreased by 34 10% and 23
18%, respectively, as were the percentages of cells in S phase
by 24 17 in presence of RA and by 18 24% in absence of
RA.
Discussion
Previous studies assessing the presence of RA receptors in
kidney cells are controversial. One study based on immunolog-
ical techniques documented the presence of CRBP and CRABP
in rat kidney [26]. In a more recent study using a bovine cDNA
probe Shubeita, Sambrook and McCormick [27] failed to isolate
any positive hybridization when kidney tissue was tested. Our
finding of CRABP in human urine after uninephrectomy [17]
supports the positive results reported by Ong, Crow and Chytil
[26]. Since this controversy is unresolved, it appeared neces-
sary to study the effect of RA on epithelial kidney cells. In
epidermal cells RA was found to have similar effects to those
observed in hypertrophy, as increase in RNAJDNA ratio was
observed [281. However, we had no information concerning the
reactivity of kidney epithelial cells to RA.
Napoli has recently assessed the metabolism of retinoids in a
pig epithelial cell line, LLC-PKI. He reported that retinal is
mostly converted to RA by this cell, while only 5% of retinol is
metabolized to RA [18]. The transport system for retinoids is
very effective and the limiting factor for increasing intracellular
RA concentration is not CRABP or CRBP, but the dehydroge-
nase which facilitates RA synthesis [18]. The present data
clearly show that kidney epithelial cells, in addition to having an
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Table 5. Effect of retino1 on RK 13 cells
Experiment
1 2
Control
l0— vitamin A
% Increase
P value
26758
25187
—5%
NS
1403
1002
4552
4540
0%
NS
184
157
Effect of retinol (vitamin A) on RK13 cells. Cells were grown in
RPMI 1640 supplemented with 10% FCS. 3H-thymidine incorporation
was measured and values are given as the mean standard error of
c.p.m. (twelve replicates were performed in each group).
Table 6. Interactions of RA and EGF in growth factor-free
conditions
C.P.M. % Increase
Control 22627 568
l0— RA 24926 359k +10%
EGF 1 ng/well 39614 783 +75%
EGF + RA 39978 l820 +77%
a P < 0.01 vs. control
3H-thymidine incorporation was measured and values are given as
the mean standard error of c.p.m.; twelve replicates were performed
in each group.
active retinoid metabolism, are reactive to RA. Thymidine
incorporation and total protein of RK13 cells are increased by
the presence of l0 M RA in the medium. The percentage of
increases were similar in both parameters, as they were in
previous epidermal cell studies [28]. Since we have observed
the same effect in logarithmically growing and confluent cells,
we can assume that RA does not act by reversing the contact
inhibition process.
Since kidney cells are able to transform several retinoids into
their metabolites, and retinal, retinol and retinoic acid synthesis
can be related [29], we also examined the effect of other
retinoids in addition to that of RA. Retinol did not have the
same effect we observed with retinoic acid, suggesting that the
effects seen with RA were not due to the activity of a major
shared metabolite of RA and retinol.
It has been previously reported that RA can modulate the
activity of other growth factors. It seems well established that
RA potentiates the effect of EGF on normal rat kidney fibro-
blasts in the presence [30] or absence [31] of transforming
growth factor beta and this effect could be secondary to an
increase in the expression of EGF receptor numbers per cell
[32]. In order to assess whether the effects we observed with
RA were due to the potentiation of any other growth factor, we
studied cells grown in the absence of FCS. Cells grown in this
serum free medium for three days also responded to RA by
taking up significantly more thymidine. It seems unlikely that
this was due to a potentiation of other pre-existing growth
factors, but more likely was due to RA itself. RK13 cells
responded to EGF addition by a marked increase in thymidine
incorporation. Additive or synergistic responses between RA
and EGF were not observed in our experiments which were
performed in serum free medium. The previous RA increased
EGF receptor expression, and thereby EGF response [32, 33],
differ from our reported experiments in that FCS was not
present; we have also observed synergistic effects between RA
Fig. 2. DNA content distribution patterns of RKJ3 cells under different
conditions. Staining acridin orange. First peak at 46 channel correspond
to resting cells in GO-Gi phase. The second peak corresponds to the
cells in G2 and M phases. The second peak is clearly increased in
non-confluent (G+) compared with confluent monolayer cultures (G—)
cells (Results).
and EGF in the presence of FCS (data not shown). It is
therefore possible to infer the requirement of a serum factor(s)
for the RA induced increase of EGF receptor expression.
Similar results have been recently reported in mouse kerati-
nocytes [34].
Kinetic studies showed that a significant increase of thymi-
dine incorporation induced by RA already occurred between
three and six hours after RA addition and lasted for the duration
of experiment.
RK 13 cells exhibited density-dependent growth inhibition as
GO/Gi = 75%
S = 8%
G2/M = 17%
Fig. 1. Total protein content in RKI3 cells in the presence () or
absence () of RA (mean standard error of 6 points). < 0.05.
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Experiment number
Fig. 3. Upper part: the number of cells in GO-Gi phases in the
presence () or absence () of RA is presented. Lower part: the bars
(U) represent the % variation induced by RA (—9.4 2%, P < 0.01).
would be expected from a non-transformed epithelial cell line.
This conclusion is derived from the flow cytometry data which
showed increased proportions of cells in G0-G 1 during conflu-
ency. This was observed in control as well as in RA stimulated
cultures and suggests that RA does not act by counteracting
contact-inhibition. Cell phase analyses therefore supported the
results obtained by thymidine incorporation and protein stud-
ies. Although RA alone was unable to overcome density-
dependent growth inhibition, RA treatment reduced the propor-
tion of resting cells (in GO-Gl phase). The cells in the other
phases were variably modified. In some experiments an in-
crease in S phase was found while in others the cells entering
the cycle were mostly observed in G2 and M phases. Compa-
rable results have been previously described for the effects of
EGF in the presence of insulin on renal fibroblasts [28, 291.
Our study demonstrates that RA is able to increase DNA
synthesis and total protein content in a kidney epithelial cell
line. Activation of the cells observed by a decreased number of
resting cells (G0-Gl cell phases) is also reported. These effects
are due to RA itself and are not directed against the density-
dependent growth inhibition. Since it is known that retinoid
metabolism is altered in kidney hypertrophy in humans and that
RA receptor metabolism or expression is locally modified in the
remaining kidney after contralateral uninephrectomy [17], the
identification of a biological effect of RA on epithelial cells
encourages further studies of the role played by retinoids and
RA in compensatory kidney growth.
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